Arthritis news and arthritis widget

Title: Rheumatoid Arthritis Exercises SlideshowCategory: SlideshowsCreated: 11/13/2008Last Editorial review: 11/14/2008

Title: New Therapy Could Transform Arthritis TreatmentCategory: health newscreated: 11/14/2008 2:00:00 amlast Editorial review: 11/14/2008

CEL-SCI Corporation presented new rheumatoid arthritis data at the 6th annual GTCbio Vaccine Conference in Vienna, Va. The data, presented by Dr. Daniel Zimmerman, Senior Vice President of Research, Cellular Immunology of CEL-SCI, indicate that CEL-SCI's rheumatoid arthritis treatment vaccine CEL-2000 prevents or retards the permanent tissue damage caused by rheumatoid arthritis. The long term results obtained with CEL-2000 vaccine, for the rheumatoid arthritis, were in line with those seen with Enbrel, a leading treatment for people with rheumatoid arthritis. read more

A variety of sign and symptoms may be linked to TMD.

Osteoarthritis treatment options involve a combination of therapies that are tailored to the patient.

Consumer Lab tests 13 brands of SAM-e and the results are surprising. Consumer Lab is a company which performs independent analyses of dietary supplements. SAM-e is also known by the names SAMe, S-adenosyl-methionine, and S-adenosyl-L-methionine.

Arthritis patients often say they are in a flare. What defines an arthritis flare?

Mobic (meloxicam) is one of the nonsteroidal anti-inflammatory drugs (NSAIDs) used to treat certain types of arthritis. Mobic was approved by the U.S. Food and Drug Administration on April 14, 2000. Mobic is available as a once a day or twice a day dose. Take Mobic only as directed for safe use.

There are various types of joint surgery. Do you know the various types? Take the quiz.

An assessment of how rheumatoid arthritis affects life expectancy.